MCLAREN FLINT
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $244K
- Transactions
- 172
- Companies
- 25
- Average per transaction
- $1,417
Who reported the payments
| Stryker | $180,525 |
| Abbott | $13,890 |
| Boston Scientific | $6,699 |
| Novartis | $5,639 |
| Olympus America Inc. | $5,005 |
| Scientia Vascular | $4,793 |
| Fujifilm Healthcare Americas Corporation | $4,000 |
| Merge Healthcare Incorporated | $3,165 |
| Incyte Corporation | $2,198 |
| Medical Device Business Services, Inc. | $2,000 |
| AstraZeneca | $1,551 |
| Chiesi USA, Inc. | $1,500 |
| Microvention, Inc. | $1,500 |
| Johnson & Johnson | $1,411 |
| Bio-rad Laboratories, Inc. | $1,055 |
| Avanir Pharmaceuticals, Inc. | $1,000 |
| Pfizer | $1,000 |
| UCB, Inc. | $1,000 |
| Penumbra, Inc. | $1,000 |
| Amgen | $1,000 |
| Genentech USA, Inc. | $1,000 |
| AbbVie | $1,000 |
| Siemens Medical Solutions USA, Inc. | $978 |
| Biotronik Inc. | $735 |
| BD | $45 |